Zhonghong Pulin Medical Products Co., Ltd. (300981.SZ)
CNY 11.83
(-0.34%)
CNY 11.83
(-0.34%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 1.12 Billion CNY | 64.37% |
| 2022 | 684.05 Million CNY | 14.47% |
| 2021 | 597.55 Million CNY | -46.5% |
| 2020 | 1.11 Billion CNY | 83.63% |
| 2019 | 608.27 Million CNY | 1.58% |
| 2018 | 598.83 Million CNY | 58.51% |
| 2017 | 377.8 Million CNY | 1.12% |
| 2016 | 373.63 Million CNY | -2.73% |
| 2015 | 384.1 Million CNY | 13.8% |
| 2014 | 337.53 Million CNY | -8.62% |
| 2013 | 369.37 Million CNY | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 1.65 Billion CNY | 47.07% |
| 2024 Q2 | 1.71 Billion CNY | 3.8% |
| 2024 Q3 | 1.62 Billion CNY | -5.24% |
| 2023 FY | 1.12 Billion CNY | 64.37% |
| 2023 Q4 | 1.12 Billion CNY | -6.41% |
| 2023 Q1 | 1.33 Billion CNY | 95.4% |
| 2023 Q2 | 1.34 Billion CNY | 0.94% |
| 2023 Q3 | 1.2 Billion CNY | -10.96% |
| 2022 Q3 | 490.83 Million CNY | -7.06% |
| 2022 Q1 | 584.96 Million CNY | -2.11% |
| 2022 FY | 684.05 Million CNY | 14.47% |
| 2022 Q4 | 684.05 Million CNY | 39.37% |
| 2022 Q2 | 528.11 Million CNY | -9.72% |
| 2021 FY | 597.55 Million CNY | -46.5% |
| 2021 Q4 | 597.55 Million CNY | 6.5% |
| 2021 Q3 | 561.09 Million CNY | -23.11% |
| 2021 Q1 | 1.04 Billion CNY | -6.04% |
| 2021 Q2 | 729.76 Million CNY | -30.47% |
| 2020 Q2 | 1.05 Billion CNY | 49.46% |
| 2020 Q3 | 1.28 Billion CNY | 22.0% |
| 2020 Q4 | 1.11 Billion CNY | -13.21% |
| 2020 FY | 1.11 Billion CNY | 83.63% |
| 2020 Q1 | 705.82 Million CNY | 16.04% |
| 2019 FY | 608.27 Million CNY | 1.58% |
| 2019 Q4 | 608.27 Million CNY | 0.0% |
| 2018 Q1 | 520.67 Million CNY | 37.82% |
| 2018 FY | 598.83 Million CNY | 58.51% |
| 2018 Q2 | 520.67 Million CNY | 0.0% |
| 2017 FY | 377.8 Million CNY | 1.12% |
| 2017 Q2 | 380.18 Million CNY | 0.0% |
| 2017 Q1 | 380.18 Million CNY | 1.76% |
| 2017 Q3 | 377.8 Million CNY | -0.63% |
| 2017 Q4 | 377.8 Million CNY | 0.0% |
| 2016 Q1 | 443.81 Million CNY | 15.54% |
| 2016 FY | 373.63 Million CNY | -2.73% |
| 2016 Q4 | 373.63 Million CNY | 0.0% |
| 2016 Q3 | 373.63 Million CNY | -15.81% |
| 2016 Q2 | 443.81 Million CNY | 0.0% |
| 2015 Q1 | 334.77 Million CNY | -0.82% |
| 2015 Q2 | 334.77 Million CNY | 0.0% |
| 2015 Q3 | 384.1 Million CNY | 14.74% |
| 2015 Q4 | 384.1 Million CNY | 0.0% |
| 2015 FY | 384.1 Million CNY | 13.8% |
| 2014 Q4 | 337.53 Million CNY | -0.29% |
| 2014 FY | 337.53 Million CNY | -8.62% |
| 2014 Q3 | 338.51 Million CNY | 0.0% |
| 2013 FY | 369.37 Million CNY | 0.0% |